Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

PD-L1 expression in squamous-cell carcinoma and adenocarcinoma of the lung

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      Sciendo, 2017.
    • Publication Date:
      2017
    • Collection:
      LCC:Medical physics. Medical radiology. Nuclear medicine
    • Abstract:
      With introduction of immunotherapy (IT) into the treatment of advanced non-small-cell lung cancer (NSCLC), a need for predictive biomarker became apparent. Programmed death ligand 1 (PD-L1) protein expression is most widely explored predictive marker for response to IT. We assessed PD-L1 expression in tumor cells (TC) and immune cells (IC) of squamous-cell carcinoma (SCC) and adenocarcinoma (AC) patients.
    • File Description:
      electronic resource
    • ISSN:
      1581-3207
    • Relation:
      https://doaj.org/toc/1581-3207
    • Accession Number:
      10.1515/raon-2017-0037
    • Accession Number:
      edsdoj.9104b551aa43462e8b685d9eeb1a62eb